Free Trial
OTCMKTS:ISCO

International Stem Cell (ISCO) Stock Price, News & Analysis

International Stem Cell logo
$0.12 -0.05 (-27.95%)
As of 12:36 PM Eastern

About International Stem Cell Stock (OTCMKTS:ISCO)

Key Stats

Today's Range
$0.12
$0.17
50-Day Range
$0.11
$0.17
52-Week Range
$0.05
$0.20
Volume
2,250 shs
Average Volume
5,143 shs
Market Capitalization
$961,280.40
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury. The company also offers anti-aging skin care products, including ProPlus Advanced Defense Complex, ProPlus Advanced Recovery Complex, ProPlus Eye Firming Complex, ProPlus Neck Firming Complex, ProPlus Advanced Aqueous Treatment, ProPlus Collagen Booster, ProPlus Elastin Booster, and ProPlus Brightening Toner. In addition, it provides human cell culture products comprising human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.

Receive ISCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter.

ISCO Stock News Headlines

Missed Nvidia? Trump’s Trade War Could Create a Bigger Winner
Missed out on Nvidia? Don’t worry — a bigger AI opportunity may be emerging right now, thanks to Trump’s newly announced tariffs. One under-the-radar U.S. semiconductor stock just gained a major edge over its foreign rivals. With demand poised to skyrocket, this chipmaker could be perfectly positioned to ride the next wave of AI growth. Shares are still flying low — but not for long.
RMS Sponsors the 5th Summit on Stem Cell Derived Islets
See More Headlines

ISCO Stock Analysis - Frequently Asked Questions

International Stem Cell's stock was trading at $0.0813 at the beginning of the year. Since then, ISCO shares have increased by 47.7% and is now trading at $0.1201.
View the best growth stocks for 2025 here
.

International Stem Cell Co. (OTCMKTS:ISCO) released its quarterly earnings results on Wednesday, May, 14th. The biotechnology company reported ($0.03) EPS for the quarter. The biotechnology company earned $2.13 million during the quarter.

Shares of ISCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Stem Cell investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Amarantus BioScience (AMBS), Fulcrum Therapeutics (FULC), Kutcho Copper (KCCFF), B2Gold (BTG) and Auxly Cannabis Group (CBWTF).

Company Calendar

Last Earnings
5/14/2025
Today
5/29/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:ISCO
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$130 thousand
Pretax Margin
-7.95%

Debt

Sales & Book Value

Annual Sales
$7.79 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
1,482,000
Market Cap
$961,280.40
Optionable
Not Optionable
Beta
-0.02

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:ISCO) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners